Chembio Diagnostics Total Assets 2006-2020 | CEMI

Chembio Diagnostics total assets from 2006 to 2020. Total assets can be defined as the sum of all assets on a company's balance sheet.
Chembio Diagnostics Annual Total Assets
(Millions of US $)
2019 $56
2018 $41
2017 $17
2016 $21
2015 $21
2014 $25
2013 $24
2012 $17
2011 $15
2010 $9
2009 $6
2008 $6
2007 $7
2006 $8
2005 $3
Chembio Diagnostics Quarterly Total Assets
(Millions of US $)
2020-03-31 $51
2019-12-31 $56
2019-09-30 $57
2019-06-30 $42
2019-03-31 $46
2018-12-31 $41
2018-09-30 $28
2018-06-30 $29
2018-03-31 $29
2017-12-31 $17
2017-09-30 $19
2017-06-30 $20
2017-03-31 $21
2016-12-31 $21
2016-09-30 $23
2016-06-30 $13
2016-03-31 $20
2015-12-31 $21
2015-09-30 $23
2015-06-30 $24
2015-03-31 $24
2014-12-31 $25
2014-09-30 $24
2014-06-30 $24
2014-03-31 $23
2013-12-31 $24
2013-09-30 $24
2013-06-30 $24
2013-03-31 $17
2012-12-31 $17
2012-09-30 $16
2012-06-30 $17
2012-03-31 $16
2011-12-31 $15
2011-09-30 $10
2011-06-30 $8
2011-03-31 $8
2010-12-31 $9
2010-09-30 $8
2010-06-30 $6
2010-03-31 $6
2009-12-31 $6
2009-09-30 $6
2009-06-30 $6
2009-03-31 $6
2008-12-31 $6
2008-09-30 $6
2008-06-30 $6
2008-03-31 $7
2007-12-31 $7
2007-09-30 $6
2007-06-30 $7
2007-03-31 $7
2006-12-31 $8
2006-09-30 $7
2006-06-30 $5
2006-03-31 $4
2005-12-31 $3
2005-09-30 $3
2005-06-30 $4
2005-03-31 $5
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.111B $0.034B
CHEMBIO DIAGNOSTICS, INC. develops, manufactures, licenses and markets proprietary rapid diagnostic tests in the growing $5 billion point-of-care testing market. Chembio's two FDA PMA-approved, CLIA-waived, rapid HIV tests are marketed in the U.S. by a third party company. Chembio markets its HIV STAT-PAK line of rapid HIV tests internationally to government and donor-funded programs directly and through distributors. Chembio also has rapid tests for veterinary tuberculosis and chagas disease. In 2007 Chembio received a U.S. patent for its Dual Path Platform technology which has significant advantages over lateral-flow technologies. This technology is providing Chembio with a significant pipeline of business opportunities for the development and manufacture of new products based on DPP. Chembio is licensed by the U.S. Food and Drug Administration as well as the U. S. Department of Agriculture, and is certified for the global market under the International Standards Organization directive 13.485.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $179.231B 33.63
Medtronic (MDT) Ireland $134.197B 21.80
Stryker (SYK) United States $71.795B 27.84
Boston Scientific (BSX) United States $55.753B 32.21
Lonza Group Ag (LZAGY) Switzerland $46.856B 0.00
Baxter (BAX) United States $40.868B 0.00
Zimmer Biomet Holdings (ZBH) United States $28.859B 23.95
Terumo (TRUMY) Japan $28.725B 36.72
EssilorLuxottica Societe Anonyme (ESLOY) France $28.171B 0.00
ResMed (RMD) United States $25.062B 36.40
Sunny Optical Technology (SNPTF) China $20.566B 0.00
Smith & Nephew SNATS (SNN) United Kingdom $18.308B 0.00
Bio-Rad Laboratories (BIO) United States $15.555B 70.35
Insulet (PODD) United States $13.735B 604.81
Shandong Weigao Medical Polymer (SHWGF) China $12.315B 0.00
Quidel (QDEL) United States $11.442B 60.61
DiaSorin S.p.A (DSRLF) Italy $11.312B 0.00
GN STORE NORD (GNNDY) Denmark $8.157B 41.58
William Demant Holdings (WILYY) Denmark $7.457B 0.00
Perrigo (PRGO) Ireland $6.885B 11.81
Hill-Rom Holdings (HRC) United States $6.336B 15.72
Canopy Growth (CGC) Canada $6.168B 0.00
Neogen (NEOG) United States $4.337B 72.47
Hutchison China MediTech (HCM) Hong Kong, SAR China $4.204B 0.00
Haemonetics (HAE) United States $4.045B 26.95
Envista Holdings (NVST) United States $3.725B 25.40
ICU Medical (ICUI) United States $3.702B 27.01
Abcam (ABCZY) $3.462B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $3.396B 0.00
Agios Pharmaceuticals (AGIO) United States $2.988B 0.00
NuVasive (NUVA) United States $2.753B 38.36
National Vision Holdings (EYE) United States $2.678B 416.25
TG Therapeutics (TGTX) United States $2.314B 0.00
DFB Healthcare Acquisitions (AHCO) United States $1.945B 0.00
AtriCure (ATRC) United States $1.911B 0.00
MacroGenics (MGNX) United States $1.484B 0.00
NanoString Technologies (NSTG) United States $1.330B 0.00
Aphria (APHA) Canada $1.287B 0.00
Aurora Cannabis (ACB) Canada $1.186B 0.00
Cerus (CERS) United States $1.173B 0.00
Cardiovascular Systems (CSII) United States $1.097B 0.00
InMode (INMD) Israel $1.016B 25.62
OraSure Technologies (OSUR) United States $1.005B 0.00
Quanterix (QTRX) United States $0.942B 0.00
PetIQ (PETQ) United States $0.895B 25.85
Lantheus Holdings (LNTH) United States $0.888B 12.31
Meridian Bioscience (VIVO) United States $0.828B 19.13
Phibro Animal Health (PAHC) United States $0.825B 16.45
Owens & Minor (OMI) United States $0.813B 18.21
Vapotherm (VAPO) United States $0.781B 0.00
Omeros (OMER) United States $0.770B 0.00
BioLife Solutions (BLFS) United States $0.671B 350.33
Surmodics (SRDX) United States $0.650B 71.25
Eagle Pharmaceuticals (EGRX) United States $0.643B 46.08
VAREX IMAGING (VREX) United States $0.640B 15.90
LeMaitre Vascular (LMAT) United States $0.600B 36.62
Zynex (ZYXI) United States $0.591B 51.64
Cytosorbents (CTSO) United States $0.412B 0.00
Viemed Healthcare (VMD) United States $0.393B 14.04
Neptune Wellness Solutions (NEPT) Canada $0.325B 0.00
HEXO (HEXO) $0.319B 0.00
Utah Medical Products (UTMD) United States $0.294B 25.22
Organigram Holdings (OGI) Canada $0.223B 0.00
Chimerix (CMRX) United States $0.211B 0.00
Female Health (VERU) United States $0.208B 0.00
Exagen (XGN) United States $0.179B 0.00
Bovie Medical (APYX) United States $0.171B 0.00
Surface Oncology (SURF) United States $0.170B 0.00
Fonar (FONR) United States $0.166B 14.75
Wound Management Technologies (SMTI) United States $0.153B 0.00
Liberty Health Sciences (LHSIF) Canada $0.128B 0.00
Green Organic Dutchman Holdings (TGODF) Canada $0.123B 0.00
Evolus (EOLS) United States $0.118B 0.00
Rockwell Medical (RMTI) United States $0.115B 0.00
Capricor Therapeutics (CAPR) United States $0.093B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.091B 0.00
MTech Acquisition (KERN) United States $0.087B 0.00
Nephros (NEPH) United States $0.071B 0.00
United-Guardian (UG) United States $0.069B 15.58
Brainsway (BWAY) Israel $0.067B 0.00
Trinity Biotech (TRIB) Ireland $0.063B 0.00
ImmuCell (ICCC) United States $0.040B 0.00
Akers Biosciences Inc (AKER) United States $0.037B 0.00
GUARDION HEALTH (GHSI) United States $0.035B 0.00
FSD PHARMA INC (HUGE) Canada $0.027B 0.00
NF Energy Saving (BIMI) China $0.023B 0.00
Conatus Pharmaceuticals (HSTO) United States $0.009B 0.00
NeuroMetrix (NURO) United States $0.009B 0.00
Senestech (SNES) United States $0.007B 0.00